Upgrade to SI Premium - Free Trial

Theralase Technologies Inc Ordinary Share (TLTFF)

0.13 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R) September 15, 2026 7:02 AM - StreetInsider Theralase(R) Releases Q2 2026 Financial Statements August 28, 2026 4:37 PM - StreetInsider Theralase(R) Closes C$3.6 Million Brokered Financing August 24, 2026 5:02 PM - StreetInsider Theralase(R) Announces $5 Million Brokered LIFE Offering August 10, 2026 5:16 PM - StreetInsider Theralase(R) Grants Stock Options August 7, 2026 5:26 PM - StreetInsider Theralase(R) Engages Global One Media to Expand Global Investor Awareness August 4, 2026 7:02 AM - StreetInsider Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus June 30, 2026 4:32 PM - StreetInsider Full Article List